Immunoassay News and Research RSS Feed - Immunoassay News and Research

Addcare’s liquid handling systems, automated immunoassay workstations, customized systems

Addcare’s liquid handling systems, automated immunoassay workstations, customized systems

Addcare Bio-Tech Co., Ltd. provides advanced liquid handling systems, automated immunoassay workstations and customized systems. [More]
Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Chemclin's Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method. [More]
Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

In Q3 of 2013, Randox announced that the Food and Drug Administration has approved the company's Acusera Immunoassay Speciality 1 quality control for use in US laboratories. [More]
Beckman announces national availability of Prostate Health Index

Beckman announces national availability of Prostate Health Index

Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non‐invasive blood test that is three times more specific in detecting prostate cancer1 than PSA (prostate‐specific antigen). [More]
Novel device uses smartphone to measure cortisol concentration in saliva

Novel device uses smartphone to measure cortisol concentration in saliva

Researchers have developed a device that uses any smartphone to measure the cortisol concentration in saliva. The device was presented Tuesday, June 24, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago. [More]
Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring's human cell line derived recombinant follicle-stimulating hormone (human rFSH), a gonadotrophin currently in phase III development. [More]
Newborn congenital adrenal hyperplasia screening justified

Newborn congenital adrenal hyperplasia screening justified

The Swedish neonatal screening programme successfully detected all cases of clinically classified salt-wasting congenital adrenal hyperplasia during a 26-year period, researchers report. [More]
Comprehensive analysis of global markets for immunoassay technologies

Comprehensive analysis of global markets for immunoassay technologies

Reportbuyer.com has added a new market research report: Immunoassays: Technologies and Global Markets [More]
Beckman Coulter to feature scientific data on the VERIS MDx System at ECCMID 2014

Beckman Coulter to feature scientific data on the VERIS MDx System at ECCMID 2014

As part Beckman Coulter’s commitment to advancing the field of molecular diagnostics the company will feature scientific data on the VERIS MDx System at the 2014 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held on 10‐13 May in Barcelona, Spain. Researchers will present five studies on the VERIS system and the company will offer an educational symposium addressing issues in viral load monitoring. The VERIS MDx System and VERIS human Cytomegalovirus (CMV) Assay received CE Marks earlier this year. [More]
VERIS MDx System from Beckman Coulter obtains CE Mark

VERIS MDx System from Beckman Coulter obtains CE Mark

Beckman Coulter Diagnostics has obtained CE Mark for the VERIS MDx System* and VERIS human Cytomegalovirus (CMV) assay*. Attaining CE Mark on the VERIS MDx System and the VERIS CMV assay are key milestones in the expansion of Beckman Coulter’s presence in molecular diagnostics. [More]
Bio-Techne makes $10M equity investment in CyVek

Bio-Techne makes $10M equity investment in CyVek

Techne Corporation, d/b/a Bio-Techne, announced today that it has made a $10 million equity investment in CyVek, Inc. (CyVek), with a commitment to acquire CyVek if certain future milestones are met. [More]

American Bio Medica's net sales decrease 7.3% in fourth quarter 2013

American Bio Medica Corporation today announced financial results for the fourth quarter and year ended December 31, 2013. [More]
Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity system with Tecan, a leading global provider of laboratory automation instruments. [More]
Mindray's net revenues increase 16.5% to $368.4 million in fourth quarter 2013

Mindray's net revenues increase 16.5% to $368.4 million in fourth quarter 2013

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. [More]
New biomarker for stress in wild animals facing global climate change

New biomarker for stress in wild animals facing global climate change

Chemical analyses by neuroscientist Jerrold Meyer and colleagues at the University of Massachusetts Amherst are helping to establish hair cortisol concentration (HCC) as an important new biomarker for stress in wild animals facing global climate change. [More]
New Access Total βhCG (5th IS) assay from Beckman Coulter receives FDA clearance and is granted CE Mark for Europe

New Access Total βhCG (5th IS) assay from Beckman Coulter receives FDA clearance and is granted CE Mark for Europe

Aligned with its commitment to help move reproductive health management forward, Beckman Coulter Diagnostics has received clearance for its new Access Total βhCG (5th IS) assay from the U.S. Food and Drug Administration (FDA) 510(k), as well as being granted the CE Mark specifically for Europe. [More]
Meridian's TRU FLU assay gets FDA clearance for analytical sensitivity claim for avian Influenza H7N9 strain

Meridian's TRU FLU assay gets FDA clearance for analytical sensitivity claim for avian Influenza H7N9 strain

Meridian Bioscience, Inc. today announced that the company's TRU FLU assay received FDA clearance for an analytical sensitivity claim for the novel avian Influenza H7N9 strain, A/Anhui/1/2013. TRU FLU is a rapid immunoassay that detects influenza A and influenza B viruses in 15 minutes in human respiratory specimens. [More]
New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

BBI Solutions, a world leader in immunoassay development and contract manufacturing, recently launched its unique range of Recombinant Fab Monoclonal Antibodies at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo, on July 28-August 31, 2013, in Houston, Texas. [More]
New 4th generation HIV assays now available to improve screening for HIV infection

New 4th generation HIV assays now available to improve screening for HIV infection

Laboratory Corporation of America Holdings announced today the availability of a 4th generation HIV antigen/antibody combination assay and a new diagnostic algorithm that improves screening for HIV infection. [More]
Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

Beckman Coulter, Inc. announces the CE Mark approval of Access 25 (OH) Vitamin D Total assay for use on the Access 2 and UniCel DxI series of immunoassay systems. Offering enhanced performance, the new assay is an important addition to the company’s bone metabolism assay menu. [More]